Horizontal transmission of hepatitis B virus-why discuss when we can vaccinate?

Journal of Infectious Diseases

Volumn 206, Issue 4, 2012, Pages 464-465

  Heiberg, Ida Louise ^a   Hogh, Birthe ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; VIRUS DNA;

ASYMPTOMATIC INFECTION; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; EDITORIAL; ENDEMIC DISEASE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; IMMIGRATION; INFECTION CONTROL; INFECTION RISK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; PRIORITY JOURNAL; SOCIAL DISCRIMINATION; STIGMA; VACCINATION; VIRUS IMMUNITY; VIRUS TRANSMISSION; ANIMAL; DISEASE TRANSMISSION; FEMALE; ISOLATION AND PURIFICATION; LACRIMAL FLUID; MALE; NOTE; VIROLOGY;

ANIMALS; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; TEARS;

EID: 84866886679     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis294     Document Type: Editorial

References (14)

1. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005; 34(Suppl 1): S1-3.
2. Davis AR, Rosenthal P. Hepatitis B in children. Pediatr Rev 2008; 29:111-9.
3. Ni YH. Natural history of hepatitis B virus infection: pediatric perspective. J Gastroenterol 2011; 46:1-8.
4. Zuckerman J, van HJ, Cafferkey M, et al. Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe? Lancet Infect Dis 2007; 7:410-9.
5. Kidd-Ljunggren K, Holmberg A, Blackberg JLindqvist B. High levels of hepatitis B virus DNA in body fluids from chronic carriers. J Hosp Infect 2006; 64:352-7.
6. van der Eijk AA, Niesters HG, Hansen BE, et al. Paired, quantitative measurements of hepatitis B virus DNA in saliva, urine and serum of chronic hepatitis B patients. Eur J Gastroenterol Hepatol 2005; 17:1173-9.
7. Heiberg IL, Hoegh M, Ladelund S, Niesters HGHogh B. Hepatitis B virus DNA in saliva from children with chronic hepatitis B infection: implications for saliva as a potential mode of horizontal transmission. Pediatr Infect Dis J 2010; 29:465-7.
8. Bereket-Yucel S. Risk of hepatitis B infections in Olympic wrestling. Br J Sports Med 2007; 41:306-10.
9. Goh KT, Ding JL, Monteiro EH, Oon CJ. Hepatitis B infection in households of acute cases. J Epidemiol Community Health 1985; 39:123-8.
10. Wasley A, Kruszon-Moran D, Kuhnert W, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 2010; 202:192-201.
11. Beutels P. Economic evaluations applied to HB vaccination: general observations. Vaccine 1998; 16 (Suppl):S84-92.
12. Houweling H, Spaendonck MC, Paulussen T, Verweij M, Ruitenberg EJ. Preparing for the next public debate: Universal vaccination against hepatitis B. Vaccine 2011; 29:8960-4.
13. Spiegel BM, Bolus R, Han S, et al. Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: the hepatitis B quality of life instrument, version 1.0. Hepatology 2007; 46:113-21.
14. Cotler SJ, Cotler S, Xie H, Luc BJ, Layden TJWong SS. Characterizing hepatitis B stigma in Chinese immigrants. J Viral Hepat 2012; 19:147-52.